Delgocitinib Uses, Dosage, Side Effects and more
Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema).
| Trade Name | Delgocitinib |
| Generic | Delgocitinib |
| Delgocitinib Other Names | Delgocitinib |
| Type | |
| Formula | C16H18N6O |
| Weight | Average: 310.361 Monoisotopic: 310.154209224 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
